arGEN-X sets terms for Euronext IPO

arGEN-X B.V. (Rotterdam, the Netherlands) plans to raise up to EUR 40 million ($54.1 million) through the sale of shares at EUR 8.50-EUR 10.25 in an IPO on NYSE Euronext and a private placement to institutional investors. Partner Shire plc (LSE:SHP; NASDAQ:SHPG) committed to purchase EUR 12 million ($16.2 million) and other shareholders have committed to purchase EUR 10 million ($13.6 million) in shares in the offering, which arGEN-X first proposed earlier this month. The first day of trading is slated for July 10. KBC Securities and Kempen are joint global coordinators and joint bookrunners; Petercam is co-lead manager and Wedbush PacGrow Life Sciences is the selling agent. ...